Dna X (SONM) Receivables - Net (2018 - 2025)
Dna X's Receivables - Net history spans 8 years, with the latest figure at $3.5 million for Q3 2025.
- Quarterly results put Receivables - Net at $3.5 million for Q3 2025, down 33.24% from a year ago — trailing twelve months through Sep 2025 was $3.5 million (down 33.24% YoY), and the annual figure for FY2024 was $4.3 million, down 83.03%.
- Receivables - Net for Q3 2025 was $3.5 million at Dna X, down from $5.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $30.3 million in Q3 2023 to a low of $2.8 million in Q3 2021.
- The 5-year median for Receivables - Net is $10.4 million (2022), against an average of $12.5 million.
- The sharpest move saw Receivables - Net soared 482.06% in 2022, then tumbled 83.03% in 2024.
- Year by year, Receivables - Net stood at $10.8 million in 2021, then soared by 107.66% to $22.4 million in 2022, then increased by 14.01% to $25.6 million in 2023, then tumbled by 83.03% to $4.3 million in 2024, then decreased by 19.38% to $3.5 million in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $3.5 million, $5.6 million, and $4.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.